191 related articles for article (PubMed ID: 30468685)
1. Motion effects in proton treatments of hepatocellular carcinoma-4D robustly optimised pencil beam scanning plans versus double scattering plans.
Pfeiler T; Ahmad Khalil D; Ayadi M; Bäumer C; Blanck O; Chan M; Engwall E; Geismar D; Peters S; Plaude S; Spaan B; Timmermann B; Wulff J
Phys Med Biol; 2018 Nov; 63(23):235006. PubMed ID: 30468685
[TBL] [Abstract][Full Text] [Related]
2. Experimental validation of a 4D dynamic dose calculation model for proton pencil beam scanning without spot time stamp considering free-breathing motion.
Tominaga Y; Oita M; Miyata J; Kato T
Med Phys; 2024 Jan; 51(1):566-578. PubMed ID: 37672227
[TBL] [Abstract][Full Text] [Related]
3. A statistical comparison of motion mitigation performances and robustness of various pencil beam scanned proton systems for liver tumour treatments.
Zhang Y; Huth I; Weber DC; Lomax AJ
Radiother Oncol; 2018 Jul; 128(1):182-188. PubMed ID: 29459153
[TBL] [Abstract][Full Text] [Related]
4. Efficient Interplay Effect Mitigation for Proton Pencil Beam Scanning by Spot-Adapted Layered Repainting Evenly Spread out Over the Full Breathing Cycle.
Poulsen PR; Eley J; Langner U; Simone CB; Langen K
Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):226-234. PubMed ID: 29254775
[TBL] [Abstract][Full Text] [Related]
5. Beam-specific planning target volumes incorporating 4D CT for pencil beam scanning proton therapy of thoracic tumors.
Lin L; Kang M; Huang S; Mayer R; Thomas A; Solberg TD; McDonough JE; Simone CB
J Appl Clin Med Phys; 2015 Nov; 16(6):5678. PubMed ID: 26699580
[TBL] [Abstract][Full Text] [Related]
6. Strategies for Motion Robust Proton Therapy With Pencil Beam Scanning for Esophageal Cancer.
Møller DS; Poulsen PR; Hagner A; Dufour M; Nordsmark M; Nyeng TB; Mortensen HR; Lutz CM; Hoffmann L
Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):539-548. PubMed ID: 33974885
[TBL] [Abstract][Full Text] [Related]
7. Mitigation of motion effects in pencil-beam scanning - Impact of repainting on 4D robustly optimized proton treatment plans for hepatocellular carcinoma.
Siregar H; Bäumer C; Blanck O; Chan M; Engwall E; Plaude S; Spaan B; Timmermann B; Wulff J
Z Med Phys; 2022 Feb; 32(1):63-73. PubMed ID: 33131995
[TBL] [Abstract][Full Text] [Related]
8. 4DMRI-based investigation on the interplay effect for pencil beam scanning proton therapy of pancreatic cancer patients.
Dolde K; Zhang Y; Chaudhri N; Dávid C; Kachelrieß M; Lomax AJ; Naumann P; Saito N; Weber DC; Pfaffenberger A
Radiat Oncol; 2019 Feb; 14(1):30. PubMed ID: 30732657
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of motion mitigation using abdominal compression in the clinical implementation of pencil beam scanning proton therapy of liver tumors.
Lin L; Souris K; Kang M; Glick A; Lin H; Huang S; Stützer K; Janssens G; Sterpin E; Lee JA; Solberg TD; McDonough JE; Simone CB; Ben-Josef E
Med Phys; 2017 Feb; 44(2):703-712. PubMed ID: 28133755
[TBL] [Abstract][Full Text] [Related]
10. Assessment of dosimetric errors induced by deformable image registration methods in 4D pencil beam scanned proton treatment planning for liver tumours.
Ribeiro CO; Knopf A; Langendijk JA; Weber DC; Lomax AJ; Zhang Y
Radiother Oncol; 2018 Jul; 128(1):174-181. PubMed ID: 29571904
[TBL] [Abstract][Full Text] [Related]
11. Proton pencil beam scanning for mediastinal lymphoma: treatment planning and robustness assessment.
Zeng C; Plastaras JP; James P; Tochner ZA; Hill-Kayser CE; Hahn SM; Both S
Acta Oncol; 2016; 55(9-10):1132-1138. PubMed ID: 27332881
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive 4D robustness evaluation for pencil beam scanned proton plans.
Ribeiro CO; Meijers A; Korevaar EW; Muijs CT; Both S; Langendijk JA; Knopf A
Radiother Oncol; 2019 Jul; 136():185-189. PubMed ID: 31015123
[TBL] [Abstract][Full Text] [Related]
13. Pencil Beam Scanning Proton Therapy for Paediatric Neuroblastoma with Motion Mitigation Strategy for Moving Target Volumes.
Lim PS; Pica A; Hrbacek J; Bachtiary B; Walser M; Lomax AJ; Weber DC
Clin Oncol (R Coll Radiol); 2020 Jul; 32(7):467-476. PubMed ID: 32081577
[TBL] [Abstract][Full Text] [Related]
14. Log file-based dose reconstruction and accumulation for 4D adaptive pencil beam scanned proton therapy in a clinical treatment planning system: Implementation and proof-of-concept.
Meijers A; Jakobi A; Stützer K; Guterres Marmitt G; Both S; Langendijk JA; Richter C; Knopf A
Med Phys; 2019 Mar; 46(3):1140-1149. PubMed ID: 30609061
[TBL] [Abstract][Full Text] [Related]
15. Proton pencil beam scanning for mediastinal lymphoma: the impact of interplay between target motion and beam scanning.
Zeng C; Plastaras JP; Tochner ZA; White BM; Hill-Kayser CE; Hahn SM; Both S
Phys Med Biol; 2015 Apr; 60(7):3013-29. PubMed ID: 25789418
[TBL] [Abstract][Full Text] [Related]
16. A Monte-Carlo-based and GPU-accelerated 4D-dose calculator for a pencil beam scanning proton therapy system.
Pepin MD; Tryggestad E; Wan Chan Tseung HS; Johnson JE; Herman MG; Beltran C
Med Phys; 2018 Nov; 45(11):5293-5304. PubMed ID: 30203550
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric uncertainties as a result of temporal resolution in 4D dose calculations for PBS proton therapy.
Zhang Y; Huth I; Weber DC; Lomax AJ
Phys Med Biol; 2019 Jun; 64(12):125005. PubMed ID: 31035271
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of rescanning technique for liver tumour treatments using a commercial PBS proton therapy system.
Zhang Y; Huth I; Wegner M; Weber DC; Lomax AJ
Radiother Oncol; 2016 Nov; 121(2):281-287. PubMed ID: 27726957
[TBL] [Abstract][Full Text] [Related]
19. 4D dose calculation for pencil beam scanning proton therapy of pancreatic cancer using repeated 4DMRI datasets.
Dolde K; Naumann P; Dávid C; Gnirs R; Kachelrieß M; Lomax AJ; Saito N; Weber DC; Pfaffenberger A; Zhang Y
Phys Med Biol; 2018 Aug; 63(16):165005. PubMed ID: 30020079
[TBL] [Abstract][Full Text] [Related]
20. A study of the beam-specific interplay effect in proton pencil beam scanning delivery in lung cancer.
Kang M; Huang S; Solberg TD; Mayer R; Thomas A; Teo BK; McDonough JE; Simone CB; Lin L
Acta Oncol; 2017 Apr; 56(4):531-540. PubMed ID: 28358666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
